FDA/CDER-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials - 02/28/2020 - 02/28/2020

The primary goal of the Workshop is to provide a forum for open discussion to improve public understanding of the significance of persistent tobacco use on outcomes in clinical trials that test therapies for cancer, cardiovascular, and pulmonary diseases.

Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news